NLS Financing

Financing - May 5, 2026

IRLAB resolves on a rights issue of approx SEK 68 million

The Board of Directors of IRLAB Therapeutics has resolved on a rights issue of shares of series A corresponding to approximately SEK 68 million.

Biotech Business - April 16, 2026

EIB backs BioLamina with EUR 20 million

The European Investment Bank (EIB) is lending EUR 20 million to BioLamina to expand its development of laminin technologies.

Financing - April 10, 2026

Isofol receives gross proceeds of SEK 18.9 million

The exercise period for warrants of series TO1 in Isofol ended on 30 March 2026 and the outcome shows that a total of 37,301,067 TO1 were exercised for subscription of 37,301,067 new shares, corresponding to a subscription rate of approximately 93.57 per cent.

Biotech Business - March 25, 2026

Tenboron receives EUR 7.6 million EU funding 

Tenboron has received a positive funding decision from the European Union Horizon Europe Health 2025 programme for Phase 1 and 2 clinical studies of its TB0010 boron carrier for Boron Neutron Capture Therapy (BNCT).

Financing - March 25, 2026

ProteomEdge raises SEK 8 million

The company has announced the completion of a second funding round, led by Navigare Ventures, a subsidiary of Wallenberg Investments, with continued strong participation from existing shareholders. 

Financing - February 24, 2026

Oncopeptides carries out a rights issue of approx SEK 200 million

The Board of Directors has resolved to carry out a new share issue of approximately SEK 200 million with preferential rights for the company’s existing shareholders based on the authorization granted by the Annual General Meeting on 22 May 2025.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.